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Abstract
Introduction Breast cancer is thought to arise in mammary
epithelial stem cells. There is, therefore, a large amount of
interest in identifying these cells. The breast is a complex tissue
consisting of two epithelial layers (an outer myoepithelial/basal
layer and an inner luminal epithelial layer) as well as a large non-
epithelial component (fibroblasts, endothelial cells,
lymphocytes, adipocytes, neurons and myocytes). The definitive
identification of a mammary epithelial stem cell population is
critically dependent on its purity. To date, this has been
hampered by the lack of suitable markers to separate out the
two epithelial layers, and to remove contaminating non-epithelial
cells.
Methods Mouse mammary glands were dissociated and
stained with CD24. Cells were sorted into separate populations
based on CD24 expression and assessed for luminal epithelial
and myoepithelial/basal markers by direct fluorescent
microscopy and real time PCR. The stem/progenitor potential of
these cell populations was assessed in vivo by cleared
mammary fat pad transplantation.
Results Three populations of CD24 expressing cells were
identified: CD24Negative, CD24Low and CD24High. Staining of
these cells with cytokeratin markers revealed that these
populations correspond to non-epithelial, myoepithelial/basal
and luminal epithelial cells, respectively. Cell identities were
confirmed by quantitative PCR. Cleared mammary fat pad
transplantation of these cell populations revealed that extensive
mammary fat pad repopulation capacity segregates with the
CD24Low cells, whilst CD24High cells have limited repopulation
capacity.
Conclusion Differential staining of mammary epithelial cells for
CD24 can be used to simultaneously isolate pure populations of
non-epithelial, myoepithelial/basal and luminal epithelial cells.
Furthermore, mammary fat pad repopulation capacity is
enriched in the CD24Low population. As separation is achieved
using a single marker, it will be possible to incorporate additional
markers to further subdivide these populations. This will
considerably facilitate the further analysis of mammary epithelial
subpopulations, whilst ensuring high purity, which is key for
understanding mammary epithelial stem cells in normal tissue
biology and carcinogenesis.
Introduction
There is increasing evidence that normal tissue stem cells are
the cells of origin of many cancers, and the identification of
such cells is, therefore, key to understanding the aetiology of
carcinogenesis [1-4]. Stem cell identification strategies rely on
the prospective isolation of candidate cell populations using
cell surface markers, followed by in vivo functional assays in
mouse models [5-7]. The accurate definition and characterisa-
tion of a potential stem cell population, however, is dependent
on its purity. The normal breast is a heterogeneous tissue, con-
sisting of two epithelial layers, an inner luminal epithelial layer
and an outer myoepithelial/basal layer, as well as non-epithelial
cells. The enormous epithelial proliferation, differentiation and
regression that occurs with each pregnancy provides indirect
evidence for the existence of a mammary epithelial stem cell.
Transplant data suggest three different mammary stem cell
compartments may exist [6] and candidate cell types have
been suggested (reviewed in [4]). Histological studies have
suggested that stem cells within the mammary epithelium are
likely to reside in a suprabasal location [4]. However, the direct
identification of mammary gland stem cells remains elusive.
This is predominantly due to the paucity of appropriate mark-
ers for the separation of the luminal epithelial and myoepithe-
lial/basal cell populations into their componentPage 1 of 6
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accurately assay populations of putative mammary stem cells
by cleared fat pad transplantation.
CD24 has generated recent interest as a potential marker of
human breast cancer stem cells [8]. To explore the potential of
this marker for isolating subpopulations of normal epithelial
cells from the adult virgin mouse mammary gland, we used
flow cytometry to investigate CD24 expression in mouse mam-
mary cell preparations. Staining with CD24 revealed three dis-
tinct cell populations: CD24High, CD24Low and CD24Negative.
Analysis of cytoskeletal antigen staining and of gene expres-
sion patterns demonstrated that these populations repre-
sented luminal epithelial, myoepithelial and non-epithelial cells,
respectively. Mammary fat pad repopulation assays revealed
that the CD24Low population is enriched for stem/progenitor
activity.
CD24-based separation of mouse mammary luminal epithelial
and myoepithelial cell populations represents a major advance
towards the prospective isolation of mammary stem cells.
Materials and methods
Preparation of single mammary cell suspensions
The fourth mammary fat pads were harvested from 20 virgin
female 10 to 12 week old FVB mice following removal of the
intra-mammary lymph nodes. Fat pads were chopped three
times with a McIlwain Tissue Chopper (Mickle Laboratory
Engineering Company, Gomshall, Surrey, UK) set to cut at
100 µm intervals and the finely minced tissue was transferred
to a digestion mix consisting of serum-free Leibowitz L15
medium (Sigma, Poole, Dorset, UK) containing 3 mg/ml colla-
genase A (Sigma) and 1.5 mg/ml trypsin (Sigma). This was
incubated for 1 h at 37°C in a shaking incubator to liberate a
mixture of epithelial tissue fragments ('organoids'), non-epithe-
lial fragments (such as pieces of blood vessel or nerve bun-
dles) and non-epithelial single cells. These were washed by
pelleting and resuspension in L15/10% FCS to remove the
collagenase mix and fatty waste, and then incubated with red
blood cell lysis buffer (Sigma) to remove erythrocytes (2 × 5
minutes). Following a further wash in L15/10% FCS, the sam-
ple was 'pre-plated' in Dulbecco's modified Eagle's medium
(Invitrogen, Paisley, UK) with 10% FCS (Sigma) for 1 h at
37°C/5% CO2. The majority of the contaminating fibroblasts,
which are single cells, attach to the tissue culture plastic in this
time, whereas the epithelial organoids do not. The epithelial
and non-epithelial fragments, and contaminating single cells
such as lymphocytes and some fibroblasts, can then be
poured off, leaving the majority of the fibroblasts behind.
To obtain single mammary epithelial cells, the organoid prepa-
rations were washed twice in Ca2+/Mg2+-free PBS/0.02% w/
v EDTA and incubated for 15 minutes in Joklik's Modification
of Minimal Essential Medium for Suspension Culture (Sigma),
to allow cell-cell contacts to begin to break down. The sample
was then pelleted and resuspended in 2 ml 0.25% w/v trypsin/
0.2% w/v EDTA in Hank's Balanced Salt Solution (Sigma).
This was incubated at 37°C for 2 minutes. Release of DNA
from damaged cells at this stage causes clumping, so after the
2 minute incubation a P1000 pipette was used to disaggre-
gate DNA clumps and then 5 ml of serum-free L15 medium
containing 1 µg/ml type I DNase (Sigma) was added. The
sample was incubated for a further 5 minutes at 37°C and then
an equal volume of L15/10% FCS added to stop the trypsini-
sation. Remaining clumps were removed by filtration through a
40 µm cell strainer and the resultant single cells pelleted,
resuspended in fresh L15/10% FCS and counted.
Flow cytometry and cell sorting
Cells were incubated at 106/ml in L15/10% FCS with anti-
CD24-fluorescein isothiocyanate (clone M1/69, BD Bio-
sciences, Oxford, UK, 0.5 µg/ml) and anti-CD45-phycoeryth-
rin-Cy5 (clone 30-F11, BD Biosciences, Oxford, UK, 0.25 µg/
ml) for 45 minutes at 4°C. Cells were washed in L15/10%
FCS and resuspended in L15/10% FCS/0.01% 4',6-diamid-
ino-2-phenylindole dihydrochloride (DAPI).
Analysis was carried out on a BD FACSVantageSE DiVa (BD
Biosciences) equipped with two Coherent 90 C-4 argon ion
lasers (Coherent, Santa Clara, CA, USA) set at 488 nm and
333.6 to 333.8 nm. Samples were gated on the basis of for-
ward- and side-scatter. Dead cells (DAPI bright) and leuko-
cytes (CD45+) were excluded. Doublets and higher order
clumps were excluded using a time-of-flight approach, where
forward-scatter-height was plotted against forward-scatter-
area. Routine examination of sorted cells revealed >99% sin-
gle cellularity.
Confocal immunofluorescent staining
Cells were sorted directly onto poly-L-lysine coated slides, air
dried, and stored at -20°C. The cells were fixed in 1:1 metha-
nol acetone at -20°C for 5 minutes and stained with antibodies
against cytokeratin (CK)14 (clone LL002, Lab Vision, Suffolk,
UK, 2.1 µg/ml) or CK8/18 (clone 5D3, Novocastra, Vision Bio-
systems, Newcastle-upon-Tyne, UK, 2 µg/ml) in addition to a
nuclear stain (DAPI). Secondary antibodies were isotype spe-
cific goat anti-mouse antibodies (A21127, A21157, A21126;
Invitrogen, Paisley, UK). Lack of non-specific staining by sec-
ondary antibodies was confirmed using isotype matched con-
trol primary antibodies (clones 15H6 and B10, Southern
Biotech, Birmingham, Alabama, USA). Lack of cross reactivity
in double staining experiments was confirmed with controls
incubated with single primary antibodies and both secondary
antibodies.
Quantitative PCR analysis
Quantitative real time reverse transcription PCR (qPCR) reac-
tions were carried out to determine fold changes in expression
of a selection of genes with known luminal epithelial (Lac-
totransferrin (Ltf), Milk Fat Globule-EGF Factor 8 proteinPage 2 of 6
(page number not for citation purposes)
Available online http://breast-cancer-research.com/content/8/1/R7(Mfge8), CK18 (Krt1-18)), myoepithelial/basal (CK14 (Krt1-
14), Myosin Light Polypeptide 6 (Myl6a)) or non-epithelial
(Myl6a, Procollagen 3a1 (Col3a1), CD31) distribution, com-
pared to leucocyte-depleted, bulk mammary cells. Populations
were freshly sorted into tubes rinsed with FCS, resuspended
in Trizol reagent (Invitrogen, Paisley, UK), and stored at -20°C.
RNA was extracted according to the manufacturer's instruc-
tions. cDNA synthesis was carried out using Sensiscript RT kit
(Qiagen, Crawley, UK). Up to 50 ng of RNA was transcribed
into cDNA using an oligo dTn primer (Promega, Southampton,
UK) per reaction; 1 µl of cDNA was used per qPCR reaction.
Each analysis reaction was performed in triplicate. GAPDH
was used as an endogenous control throughout all experimen-
tal analyses. Gene expression analysis was performed using
TaqMan Gene Expression Assays on an ABI Prism 7900HT
sequence detection system (Applied Biosystems, Foster City,
California, USA). Analysis was performed using the ∆-∆Ct
method, which determines fold changes in gene expression
relative to a comparator sample (mammary epithelial cells that
had been depleted for CD45+ cells but not separated further).
Significant deviation of the mean value of each sample group
from a fold difference of 1 (no change compared to the com-
parator sample) was tested using a t-test on Log10 trans-
formed data. Standard curves were derived from sequence
verified cDNA IMAGE clones (MRC Geneservice, Cambridge,
UK) for each gene of interest confirming that sample amplifica-
tion was within the linear range of the assay (data not shown).
Cleared mammary fat pad transplantation
Freshly isolated cells were low pressure sorted into sterile
screw-cap Eppendorf tubes and pelleted in an Eppendorf
benchtop microfuge at 700 × g for 5 minutes. Cell pellets
were resuspended in fresh PBS, counted, and resuspended in
serum-free L15 medium at an appropriate cell density (such
that 10 µl of serum-free L15 contained the number of cells to
be implanted in each fat pad). There was no intervening culture
period prior to transplantation.
Transplantation into cleared fourth mammary fat pads of 21-
day old syngeneic female mice was carried out as described
[5]. All animal work was approved by Local Ethics Committee
and carried out under Home Office approval. Eight weeks after
transplantation, fat pads were wholemounted and analysed as
described [5]. They were scored as negative for outgrowth if
no epithelial structures could be observed. They were scored
as 'failed clears' if they contained an epithelial ductal network
that could be seen to have grown in from one edge of the fat
pad and in which the majority of ductal branching had the
same directionality. If outgrowths could be seen to have origi-
nated from a central region of the cleared fat pad and the
directionality of the ductal branching was different in different
parts of the fat pad, they were scored as successful trans-
plants. Successful transplants had a region of epithelial out-
growth dissected out under a binocular microscope for
paraffin embedding by routine methods and routine immuno-
cytochemistry to detect α-isoform smooth muscle actin (clone
1A4; Sigma).
Results
Staining with CD24 consistently revealed three distinct popu-
lations: CD24High (69.9 ± 5.5%), CD24Low (22.2 ± 5.6%), and
CD24Negative (6.3 ± 1.5%) (results from 15 independent sorts;
Fig. 1). To examine the phenotype of these populations, cells
were sorted directly onto poly-L-lysine coated slides and
stained with antibodies against CK8/18, expressed exclu-
sively by luminal epithelial cells in vivo, or CK14, expressed
exclusively by myoepithelial/basal cells in vivo. Of the
CD24High population, 99.1 ± 1.7% (n = 488 cells from 4 inde-
pendent sorts) were CK8/18+ luminal cells. Of the CD24Low
population, 94.7 ± 4.1% (n = 589 cells from 4 independent
sorts) were CK14+ myoepithelial/basal cells. The majority of
CD24Negative cells were both CK8/18 negative and CK14 neg-
ative, indicating that this population comprised mainly non-epi-
thelial cell types (Fig. 2a). Double staining of cells for both
CK8/18 and CK14 (Fig. 2b) revealed the presence of CK neg-
ative cells within the CD24Low population (bottom panel,
inset), but failed to identify cells in any population that were
both CK8/18+ and CK14+ (data not shown).
To independently assess the luminal epithelial, myoepithelial/
basal and non-epithelial nature of the CD24High, CD24Low and
CD24Negative cells, respectively, qPCR for a selection of genes
was undertaken. Genes associated with luminal epithelial cell
function (Ltf and Mfge8) were significantly (p < 0.01) enriched
in the CD24High population. Genes associated with myoepi-
thelial/basal cells (Krt1-14, Myl6) were similarly enriched in
the CD24Low cells (p < 0.001). Expression of CD31 was sig-
nificantly (p < 0.001) elevated in the CD24Negative population,
confirming that this population was non-epithelial (Fig. 2c and
Additional file 1; results from three independent sorts).
To demonstrate the value of CD24 staining of mouse mam-
mary cell populations for mammary epithelial stem cell discov-
ery, cells from each of the three populations defined by CD24
staining were transplanted into the cleared mammary fat pads
of syngeneic mice. CD24Low cells had the greatest outgrowth
potential, with 1,000 cells producing outgrowths in 2 of 5
cases (Fig. 3a). CD24Low cells also had the most extensive
mammary fat pad repopulating capacity, and could give rise to
outgrowths that filled the entire fat pad (Fig. 3a,b) and con-
sisted of both luminal epithelial and myoepithelial cell layers
(Fig. 3d). CD24High cells formed fewer outgrowths than
CD24Low cells and had a limited repopulating capacity, form-
ing outgrowths that only filled up to 25% of the mammary fat
pad, even when 15,000 cells were injected (Fig. 3a,c).
Discussion
The primary goal of mammary epithelial separation strategies
is to define a population of mammary epithelial stem cells for
functional analysis. To date, two such strategies have beenPage 3 of 6
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population [5,9], and the use of the cell surface marker Sca-1
[7]. There is some evidence that mammary epithelial cells lying
within the side population are enriched for stem activity [5,10].
Analysis of these experiments is confounded, however, by the
toxic effects of Hoechst 33342 on cell viability [11]. Further-
more, Bcrp1 (the pump responsible for the efflux of Hoechst
33342) is present and active in mature secretory luminal cells,
indicating that it cannot be an exclusive stem cell marker [12].
Sca-1, a marker of haematopoietic stem cells, is expressed on
20% of mammary gland cells, and Sca-1+ cells have been sug-
gested to be enriched for stem activity [7]. However, a subset
of stromal cells are Sca-1+ [13] (M Smalley, data not shown),
indicating that Sca-1+ cells freshly isolated from the mammary
gland are a heterogeneous mix of epithelial cells and
fibroblasts.
The accurate identification of an epithelial stem cell subpopu-
lation is critically dependent on its purity. Current methods for
the isolation of luminal epithelial and myoepithelial cells from
Figure 1
Differential CD24 expression distinguishes between mammary gland subtypes
subtypes. (a) Cells were sorted on the basis of forward scatter and side 
scatter. (b) Dead cells (DAPI bright) were excluded. (c) B lymphocytes 
and immature T lymphocytes are CD24+ and, therefore, CD45 staining 
was used to exclude all leukocytes. (d) Doublets and higher order cell 
clumps were excluded using a time-of-flight approach (boxed cells rep-
resent single cells). (e) Typical CD24 staining profile, indicating the 
three populations of cells: CD24High (69.9 ± 5.5%; n = 15), CD24Low 
(22.2 ± 5.6%; n = 15) and CD24Negative (6.3 ± 1.5%; n = 15). DAPI = 
4',6-diamidino-2-phenylindole dihydrochloride; FITC, fluorescein isothi-
ocyanate; PE-Cy5, phycoerythrin-Cy5.
Figure 2
Characterisation of CD24High, CD24Low and CD24Negative populations. 
(a) Cell populations sorted on the basis of CD24 expression were 
stained for cytokeratin (CK)8/18 or CK14. The mean percentage of 
CK14 and CK8/18 positive cells (±standard deviation) and the total 
number of cells counted is indicated for each population. Results from 
four independent sorts. (b) Cells were double stained with CK14 and 
CK8/18. Only CK18+/CK14- cells were observed in the CD24High pop-
ulation (top panel). The majority of CD24Low cells were CK14+, with 
occasional CK18-/CK14- cells (bottom panel, inset). No CK18+/CK14+ 
cells were observed. Scale bar = 75 µm. (c) Quantitative rtPCR reac-
tions were carried out to determine fold changes in expression of a 
selection of genes with known luminal epithelial (Ltf, Mfge8, Krt1-18), 
myoepithelial/basal (Krt1-14, Myl6a) or non-epithelial (Myl6a, Procolla-
gen 3a1 (Col3a1), CD31) distribution, compared to leucocyte-
depleted, bulk mammary cells. The analysis was carried out on two 
independent cDNA syntheses from each of three independent sorts 
(CD24Low and CD24High) or on two independent cDNA syntheses from 
one sort and a single cDNA synthesis from a pool of two further sorts 
(CD24Negative). Significance levels are indicated by: *P < 0.05; **P < 
0.01; ***P < 0.001.Page 4 of 6
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monoclonal antibodies, 33A10 and JB6, respectively [14].
These antibodies are not available as fluorochrome conju-
gates; therefore, it has not been possible to isolate both of
these epithelial populations whilst simultaneously avoiding
non-epithelial cells. Furthermore, recent data indicate that
33A10 does not stain the total luminal epithelial cell popula-
tion (M Smalley, manuscript in preparation). The data shown
here demonstrate that differential staining of CD24 can be
used for the simultaneous isolation of mouse mammary luminal
epithelial, myoepithelial/basal and non-epithelial cells at high
levels of purity. Furthermore, it has been shown that whilst a
mammary epithelial progenitor cell with limited outgrowth
potential is found within the CD24High cells, extensive mam-
mary fat pad repopulation ability segregates with the CD24Low
population. This is consistent with the balance of evidence,
which suggests that stem cells reside in a suprabasal location
[4]. The incorporation of multiple additional fluorochromes for
flow cytometric separation will enable these stem/progenitor
cells to be definitively isolated. Consequently, this method will
prove indispensable for the functional analysis of mammary
gland epithelial subpopulations, which is essential for under-
standing the role of stem cells in normal tissue biology and
carcinogenesis.
Conclusion
We describe a simple and efficient procedure for the simulta-
neous identification and isolation of luminal epithelial, myoepi-
thelial/basal and non-epithelial cells from the mouse mammary
gland, and show that extensive mammary fat pad repopulating
ability segregates with the myoepithelial/basal population.
CD24 staining of the mouse mammary epithelium has three
significant advantages over any current mammary gland cell
separation strategy. First, it provides a simple and efficient
means of separating mouse mammary epithelial from non-epi-
thelial cells. Second, it enables simultaneous identification and
isolation of pure populations of luminal and myoepithelial cells.
Third, as separation is achieved with a single marker, CD24
can be used in conjunction with multiple additional markers for
the prospective isolation of mammary stem cells. This repre-
sents a major advance in the study of mouse mammary gland
biology.
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Figure 3
Transplantation of CD24High, CD24Low and CD24Negative populations. 
Cell populations sorted on the basis of CD24 expression were trans-
planted into cleared mammary fat pads of syngeneic FVB mice. (a) 
Table indicates the number of cells of each population injected into 
each fat pad, the total number of fat pads injected, and the number of 
transplants that generated epithelial outgrowths. Failed clears were 
excluded from the analysis. The extent to which each outgrowth filled 
the host fat pad is indicated graphically. CD24Low cells showed the 
highest rate of successful transplantation and formed the most exten-
sive outgrowths at each cell number studied. (b) Example of an out-
growth derived from transplantation of CD24Low cells that fills 100% of 
the host fat pad. The magnified boxed region highlights the point of ori-
gin of the outgrowth. Scale bar = 4.25 mm. (c) Example of an out-
growth derived from transplantation of CD24High cells which fills <25% 
of the host fat pad. Scale bar = 4.25 mm. (d) Section through CD24Low 
outgrowth stained with anti-α-isoform smooth muscle actin showing the 
positive outer myoepithelial layer (arrows) and the negative inner luminal 
epithelial layer (arrowheads). Scale bar = 40 µm.Page 5 of 6
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